Despite growing demand, Mounjaro faces intermittent supply shortages in India due to import dependencies and regulatory hurdles
Source: Drug Discovery and Development Novo Nordisk confirmed in their reporting that more than 4 million patients around the world are using GLP-1 drugs for obesity treatment
However, the longer-term impact of GLP-1RAs is likely to be positive for the industry, driven by an expected higher uptake of physical activity by previously overweight individuals, and the growing evidence of the importance of exercise to preserving muscle mass
Short-acting formulations like exenatide (Byetta) clear within 1224 hours, while long-acting options such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) can take 45 weeks to fully eliminate
NAC is a precursor to glutathione
To support immunity and recovery, choose the agent based on your priority: immune cell support/detox glutathione